glp 1 drugs and thyroid GLP-1 receptor agonist use for more than year may increase cancer risk GLP-1 Medications: Everything You Need

(2003), in a human study, treated elderly human subjects with epithalamin for two to three years, noting a 1.6-1.8 fold decrease in mortality compared with a control group

The safety of CoQ10 during breastfeeding is inadequately studied, with insufficient evidence to confirm safety for nursing mothers and infants

Nutrients 17(9)

Photo by Innerbody Research Around 30-50% of American adults dont get enough sleep.1 The consequences of this insufficiency can be steep, as without a regular 7-8 hours rest per night, a person can find themselves at risk for depression, decreased cognitive function, and an increased risk of cardiovascular and endocrine dysfunction.2 For the many millions of people with sleep deficiency, a peptide called DSIP could be a solution, although some researchers might disagree

Introduction and Background GLP-1 receptor agonists (GLP-1 RAs) are a class of peptide-based drugs that mimic the human incretin hormone glucagon-like peptide-1

Wolff J., Chaikoff I.L